Literature DB >> 600183

Metoclopramide in migrane treatment.

J B Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 600183

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  8 in total

Review 1.  5-HT3 receptor antagonists and migraine therapy.

Authors:  M D Ferrari
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

Review 2.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 3.  Migraine: pharmacotherapy in the emergency department.

Authors:  A M Kelly
Journal:  West J Med       Date:  2000-09

4.  Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials.

Authors:  Ian Colman; Michael D Brown; Grant D Innes; Eric Grafstein; Ted E Roberts; Brian H Rowe
Journal:  BMJ       Date:  2004-11-18

5.  [Therapy for migraine-the current state of the art and perspectives.].

Authors:  D Soyka
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

Review 6.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

7.  Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity.

Authors:  S E Banner; G J Sanger
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Metoclopramide versus sumatriptan for treatment of migraine headache: A randomized clinical trial.

Authors:  Saeid Talabi; Babak Masoumi; Reza Azizkhani; Mehrdad Esmailian
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.